5.06
price down icon11.54%   -0.66
 
loading
前日終値:
$5.72
開ける:
$5.73
24時間の取引高:
6.74M
Relative Volume:
1.56
時価総額:
$1.20B
収益:
$251.85M
当期純損益:
$-72.58M
株価収益率:
-16.15
EPS:
-0.3134
ネットキャッシュフロー:
$-63.80M
1週間 パフォーマンス:
-12.61%
1か月 パフォーマンス:
+3.05%
6か月 パフォーマンス:
-20.57%
1年 パフォーマンス:
-40.47%
1日の値動き範囲:
Value
$5.05
$5.73
1週間の範囲:
Value
$5.05
$6.55
52週間の値動き範囲:
Value
$4.32
$9.83

Ardelyx Inc Stock (ARDX) Company Profile

Name
名前
Ardelyx Inc
Name
セクター
Healthcare (1169)
Name
電話
510-745-7047
Name
住所
34175 ARDENWOOD BLVD., FREMONT, CA
Name
職員
267
Name
Twitter
@ardelyx
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
ARDX's Discussions on Twitter

ARDX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ARDX
Ardelyx Inc
5.06 1.20B 251.85M -72.58M -63.80M -0.3134
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Ardelyx Inc Stock (ARDX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-11-11 ダウングレード H.C. Wainwright Buy → Neutral
2024-07-02 ダウングレード Piper Sandler Overweight → Neutral
2024-04-05 開始されました Leerink Partners Outperform
2023-12-18 開始されました Raymond James Strong Buy
2023-09-07 開始されました H.C. Wainwright Buy
2023-08-25 アップグレード Cantor Fitzgerald Neutral → Overweight
2023-03-03 アップグレード Wedbush Neutral → Outperform
2022-11-17 アップグレード Piper Sandler Neutral → Overweight
2022-05-06 ダウングレード Cantor Fitzgerald Overweight → Neutral
2021-12-01 アップグレード Ladenburg Thalmann Neutral → Buy
2021-10-14 ダウングレード Ladenburg Thalmann Buy → Neutral
2021-07-21 ダウングレード Jefferies Buy → Hold
2021-07-20 ダウングレード Piper Sandler Overweight → Neutral
2021-07-20 ダウングレード Wedbush Outperform → Neutral
2021-03-23 開始されました Wedbush Outperform
2021-01-06 開始されました Cantor Fitzgerald Overweight
2020-10-20 再開されました Citigroup Buy
2020-02-18 再開されました Jefferies Buy
2020-02-12 開始されました Citigroup Buy
2020-02-10 開始されました Cowen Outperform
2019-04-08 開始されました Piper Jaffray Overweight
2018-08-24 開始されました Jefferies Buy
2018-03-19 再開されました Leerink Partners Outperform
2017-11-29 繰り返されました Citigroup Buy
2017-11-22 繰り返されました Ladenburg Thalmann Buy
2017-10-17 再開されました Leerink Partners Outperform
2016-03-31 開始されました Ladenburg Thalmann Buy
2016-03-09 開始されました Cantor Fitzgerald Buy
2016-03-03 開始されました Citigroup Buy
すべてを表示

Ardelyx Inc (ARDX) 最新ニュース

pulisher
Feb 21, 2025

Ardelyx CFO Justin Renz sells $29,076 in stock By Investing.com - Investing.com South Africa

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx (ARDX) Earnings Call: Strong Growth Amidst Challenges - TipRanks

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx chief legal officer sells $24,128 in stock By Investing.com - Investing.com South Africa

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx chief medical officer Laura Williams sells $27,783 in stock - Investing.com India

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx chief medical officer Laura Williams sells $27,783 in stock By Investing.com - Investing.com Australia

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx CEO Michael Raab sells $129,124 in company stock - Investing.com

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx CFO Justin Renz sells $29,076 in stock - Investing.com

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx Executives Sell Shares to Cover Tax Obligations - TradingView

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx chief legal officer sells $24,128 in stock - Investing.com

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx, Inc. (NASDAQ:ARDX) Q4 2024 Earnings Call Transcript - MSN

Feb 21, 2025
pulisher
Feb 21, 2025

H.C. Wainwright holds Ardelyx stock at $5.50 target, neutral stance By Investing.com - Investing.com Australia

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx (NASDAQ:ARDX) Releases Earnings Results, Hits Estimates - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx price target lowered to $13 from $15 at Raymond James - TipRanks

Feb 21, 2025
pulisher
Feb 21, 2025

H.C. Wainwright holds Ardelyx stock at $5.50 target, neutral stance - Investing.com

Feb 21, 2025
pulisher
Feb 21, 2025

Breaking Down Ardelyx: 4 Analysts Share Their Views - Benzinga

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx Stock Rises After-Hours On Q4 Beat, Drug Sales Outlook: Retail Gets Big Dose Of Optimism - MSN

Feb 21, 2025
pulisher
Feb 21, 2025

Ardelyx Inc. Grapples with Trade Secret Risks Threatening Financial Stability - TipRanks

Feb 21, 2025
pulisher
Feb 20, 2025

Ardelyx Reports Strong 2024 Financial Performance - TipRanks

Feb 20, 2025
pulisher
Feb 20, 2025

Ardelyx: Q4 Earnings Snapshot - mySA

Feb 20, 2025
pulisher
Feb 20, 2025

Ardelyx, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

ARDELYX, INC. SEC 10-K Report - TradingView

Feb 20, 2025
pulisher
Feb 20, 2025

Ardelyx, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

Ardelyx Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 20, 2025
pulisher
Feb 20, 2025

Ardelyx (ARDX) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance

Feb 20, 2025
pulisher
Feb 20, 2025

Earnings call transcript: Ardelyx beats Q4 2024 forecasts, stock dips - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

Ardelyx Inc earnings beat by $0.01, revenue topped estimates - Investing.com Nigeria

Feb 20, 2025
pulisher
Feb 20, 2025

Ardelyx (ARDX) Meets Q4 Earnings Estimates - Yahoo Finance

Feb 20, 2025
pulisher
Feb 20, 2025

Earnings Flash (ARDX) Ardelyx Posts Q4 EPS $0.02, vs. FactSet Est of $0.03 -February 20, 2025 at 07:54 am EST - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times

Feb 20, 2025
pulisher
Feb 20, 2025

Can Ardelyx's $334M Revenue and Dual Blockbuster Strategy Transform Biotech Investment? - StockTitan

Feb 20, 2025
pulisher
Feb 19, 2025

Shareholders of Ardelyx, Inc. Should Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your RightsARDX - ACCESS Newswire

Feb 19, 2025
pulisher
Feb 19, 2025

Ardelyx (NASDAQ:ARDX) Trading Up 7.9%Here's Why - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference - The Manila Times

Feb 19, 2025
pulisher
Feb 19, 2025

Can Ardelyx's Presentation at TD Cowen Conference Reveal New Growth Catalysts? - StockTitan

Feb 19, 2025
pulisher
Feb 18, 2025

Ardelyx, Inc. (NASDAQ:ARDX) Sees Significant Increase in Short Interest - MarketBeat

Feb 18, 2025
pulisher
Feb 18, 2025

ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 18, 2025
pulisher
Feb 18, 2025

Ardelyx (ARDX) to Release Earnings on Thursday - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

Ardelyx director David Mott buys $992,671 in company stock - MSN

Feb 17, 2025
pulisher
Feb 17, 2025

There's No Escaping Ardelyx, Inc.'s (NASDAQ:ARDX) Muted Revenues - Simply Wall St

Feb 17, 2025
pulisher
Feb 16, 2025

Ardelyx spikes as chairman buys nearly $1M worth of stock - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

Ardelyx (ARDX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Feb 16, 2025
pulisher
Feb 13, 2025

(ARDX) Technical Data - Stock Traders Daily

Feb 13, 2025
pulisher
Feb 13, 2025

Ardelyx (ARDX) Earnings Expected to Grow: Should You Buy? - Nasdaq

Feb 13, 2025
pulisher
Feb 11, 2025

Ardelyx, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your RightsARDX - ACCESS Newswire

Feb 11, 2025
pulisher
Feb 11, 2025

ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire

Feb 11, 2025
pulisher
Feb 10, 2025

Shareholders that lost money on Ardelyx, Inc.(ARDX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

Feb 10, 2025
pulisher
Feb 07, 2025

ARDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 07, 2025
pulisher
Feb 05, 2025

State Street Corp Reduces Stake in Ardelyx Inc: Analyzing the Im - GuruFocus.com

Feb 05, 2025
pulisher
Feb 05, 2025

Ardelyx (NASDAQ:ARDX) Upgraded to "Strong-Buy" at Cantor Fitzgerald - MarketBeat

Feb 05, 2025
pulisher
Feb 05, 2025

Ardelyx, Inc. (NASDAQ:ARDX) CEO Michael Raab Sells 41,666 Shares - MarketBeat

Feb 05, 2025
pulisher
Feb 04, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx, Inc. LawsuitARDX - ACCESS Newswire

Feb 04, 2025

Ardelyx Inc (ARDX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
大文字化:     |  ボリューム (24 時間):